Europe’s Road towards Open Science and Open Access – where do Plan S and Projekt DEAL lead us?
## Due to the increasing number of corona cases, we changed the event from a real-life event to a virtual event. Instead of the live stream, the event will be held as a zoom webinar (Join here: https://embl-de.zoom.us/webinar/register/WN_VZAQ6IkQT7KG40iEnhfMBg). We apologize for the inconvenience. ##
For more than twenty years the Open Access movement has been trying to remove access barriers to scientific results. However, today this goal has still not been fully achieved. Initiatives for Open Access publishing like Plan S – supported by cOAlition S, an international consortium of research funders – or transformative agreements like the German Projekt DEAL try to turn Open Access into the standard for scientific publishing. At the same time, the main actors – researchers, publishers, libraries and research funders – continue to have very different views on how to achieve the goal of open access.
On the occasion of this year’s Open Access week, renowned representatives from science, publishers and libraries will discuss the current developments in Europe based on the concrete examples of Plan S and Projekt DEAL.At the joint event organized by EMBL Szilárd Library and EMBO press, Dr. Ralf Schimmer, deputy director of the Max Planck Digital Library, Dr. Guido F. Herrmann, Managing Director of Germany and Vice President at John Wiley & Sons, and Prof. Dr. Maria Leptin, Director of EMBO, discuss the topic of Europe’s Road towards Open Science and Open Access – where do Plan S and Projekt DEAL lead us?
Join us on Tuesday, 20th October 2020, 5.00pm-7.30pm (CEST) via Zoom (https://embl-de.zoom.us/webinar/register/WN_VZAQ6IkQT7KG40iEnhfMBg)
Please join us also for the (EMBL internal) virtual WorkshopOpen Access Publishing in Life Science – How EMBL Researchers Can Benefit from Wiley’s Open Access Agreements on Wednesday, 21st October 2020 at 3pm (more information) and the Webinar Journal-independent peer review of preprints by Thomas Lemberger (EMBO Press) and Sara Monaco (Review Commons) on Wednesday, 21st October 2020 at 4pm.
Prof. Dr. Maria Leptin, Director of EMBO
Maria Leptin received her PhD in 1983 for work on B cell activation carried out at the Basel Institute for Immunology, Switzerland. She studied the development of Drosophila as a postdoc at the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge, UK. She spent 1989-1994 as a group leader at the Max Planck Institute in Tübingen, Germany and became Professor at the Institute of Genetics, University of Cologne, in 1994. She spent extended research periods and sabbatical visits at the University of California San Francisco (UCSF), USA, the École normale supérieure in Paris, France, and the Wellcome Trust Sanger Institute at Hinxton, UK.
In January 2010, Maria Leptin was appointed Director of EMBO. Her research group at the European Molecular Biology Laboratory (EMBL) studies the cell biology and biophysics of cell shape changes.
Maria Leptin is an elected member of EMBO, the Academia Europaea, the German National Academy, Leopoldina, and an Honorary Fellow of the UK Academy of Medical Sciences. She is Deputy Director of the Christiane-Nüsslein-Volhard Stiftung, member of the selection panel for the Eppendorf Award for Young European Investigators, has chaired evaluation panel for ERC Advanced Investigator Grants, and Synergy Grants, serves on the editorial boards ofleading journals, and on advisory boards of several academic institutions and selection panels for funding institutions.
Dr. Guido F. Herrmann, Managing Director of Germany and Vice President at John Wiley & Sons, Inc.
Dr. Guido F. Herrmann has been Managing Director of Germany and Vice President at John Wiley & Sons, Inc. since April 2017. Dr. Herrmann is responsible for business operations in Germany and leads a substantial portion of Wiley’s global journal portfolio, with primary responsibility for titles in the physical and medical sciences. He joined Wiley from Georg Thieme Verlag, where he has worked for 20 years as Managing Director. Dr. Herrmann serves as Chair of the STM Copyright Enforcement Task Force and sits on the Supervisory Board of VG Wort, the German reproduction rights organization. He is a past member of the Supervisory Board of FIZ Karlsruhe, where he also chaired the Scientific Advisory Board for many years.
Dr. Ralf Schimmer, Deputy Director and Head of Information at Max Planck Digital Library
Ralf Schimmer leads the licensing strategy of the Max Planck Digital Library, serving the 80+ advanced research institutes of the Max Planck Society. A champion of open access in scholarly communications, he chaired the Governing Council of SCOAP3 (2014-2016), serves on many international boards (e.g. Knowledge Unlatched and Fair Open Access Alliance), and is a leader for the Open Access 2020 Initiative. With his team, he is now also operating the German DEAL agreements with Wiley and Springer Nature.
2020-10-20: 5pm-7.30pm (CEST), watch via Zoom (https://embl-de.zoom.us/webinar/register/WN_VZAQ6IkQT7KG40iEnhfMBg)
5.00pm – 5.10pm: Welcome and Introduction (Dr. Bastian Drees, EMBL Szilárd Library)
5.15pm – 5.35pm: Dr. Guido Herrmann (Wiley)
5.40pm – 6.00pm: Dr. Ralf Schimmer (MPDL)
6.05pm – 6.25pm: Prof. Dr. Maria Leptin (EMBL & EMBO)
6.30pm – 7.30pm: Panel Discussion with the three speakers (Moderator: Dr. Bernd Pulverer, EMBO press)
2020-10-21: 3pm-4.30pm (CEST)
3.00pm – 4.00pm: Workshop: Open Access Publishing in the Life Sciences (Wiley)
4.00pm – 4.30pm: Journal-independent peer review of preprints (Thomas Lemberger (EMBO Press) and Sara Monaco (Review Commons))